The Economic Times

Ebola vaccine update: Russia claims a breakthrough; Oxford researchers, Serum Institute of India aim to begin trial in 3 months

A new Ebola vaccine developed by Russian scientists shows promise against the current outbreak strain in the Democratic Republic of Congo. Researchers at Oxford University are also rapidly advancing vaccine development. These efforts aim to combat the fast-growing outbreak. The vaccines utilize established technology for quicker production. International partners are collaborating to scale up manufacturing and response measures.